Lars Fruergaard Jorgensen
Lars Fruergaard Jorgensen is the CEO of Novo Nordisk, a Danish pharmaceutical company renowned for its innovative treatments for diabetes and obesity. Under his leadership, the company has focused on expanding its portfolio of obesity medications, including the highly successful Wegovy. Jorgensen has emphasized the strong demand for obesity treatments, despite market fluctuations and competition from other pharmaceutical companies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Denmark | 3 | 4.67 | 0.23% | +0% | 5,792,202 | 13,295 | $350,000 | 803$ |
| Switzerland | 1 | 5.00 | 0.08% | +0% | 8,654,622 | 6,913 | $700,000 | 559$ |
| United Kingdom | 1 | 5.00 | 0.04% | +0% | 67,886,011 | 28,464 | $2,700,000 | 1,132$ |
| Totals | 5 | 82,332,835 | 48,672 | $3,750,000 | 2,494$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Lars Fruergaard Jörgensen was the long-time CEO of Novo Nordisk before being dismissed.
5
Australia:
Lars Fruergaard Jorgensen, Novo’s former Chief Executive Officer, was called to testify about the pricing of his company’s drugs.
5
Iceland:
Lars Fruergaard Jorgensen is the CEO of Novo Nordisk.
7
Pakistan:
Lars Fruergaard Jorgensen was the CEO of Novo Nordisk who was ousted over concerns about the company's market position.
4
Switzerland:
Lars Fruergaard Jörgensen led Novo Nordisk to success but was unexpectedly dismissed in May.
5
Canada:
Lars Fruergaard Jorgensen was forced out as chief executive of Novo Nordisk.
4
Italy:
Lars Fruergaard Jorgensen will leave his position as CEO of Novo Nordisk after the company's stock fell over 50% in the last 12 months.
4
United States:
Lars Fruergaard Jorgensen is stepping down as CEO of Novo Nordisk due to recent market challenges.
5
Switzerland:
Lars Fruergaard Jörgensen was the CEO of Novo Nordisk and is stepping down after eight years due to market challenges.
5
Canada:
Novo Nordisk CEO Lars Fruergaard Jorgensen said on a call with journalists that growth is expected to pick up in the second-half of the year.
6